Pharmacotherapy

Article	Citations
Comment on “Hydrocortisone versus vasopressin for the management of adult patients with septic shock refractory to norepinephrine: A multicenter retrospective study”	74
Standards of practice to advance the quality of health care	69
Population pharmacokinetic model‐guided optimization of intravenous voriconazole dosing regimens in critically ill patients with liver dysfunction	56
Correlation between heparin anti‐Xa activity and thromboelastography in adult critically ill COVID‐19 patients	39
	38
Empiric dosing strategies to predict lamotrigine concentrations during pregnancy	36
Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment‐experienced and/or have multidrug‐resistant HIV‐1: Endorsed by the Am	34
Dosing implications for liposomal amphotericin B in pregnancy	31
Current clinical pharmacology issues in pregnancy and pediatrics	30
Enhancing pharmacokinetic and pharmacodynamic knowledge in pediatrics	30
Association of atrial fibrillation with lamotrigine: An observational cohort study	29
Characterization of lamotrigine disposition changes during and after pregnancy in women with epilepsy	28
Issue Information	27
	25
Issue Information	25
Comparison of risk‐scoring systems for heparin‐induced thrombocytopenia in cardiac surgery patients	25
	24
Thirty‐day risk of digoxin toxicity among older adults co‐prescribed trimethoprim‐sulfamethoxazole versus amoxicillin: A population‐based cohort study	21
The safety of rapid infusion levetiracetam: A systematic review	21
Myocardial infarction associated with erenumab: A case report	21
Update on the clinical applications of SGLTis: Insight to benefits beyond hypoglycemic and cardiorenal protection	20
Successful prolonged treatment of a carbapenem‐resistant Acinetobacter baumannii hip infection with cefiderocol: A case report	19
Fixed dose daptomycin: An opportunity for pharmacokinetic/pharmacodynamic optimization in Staphylococcus aureus infections	19
Evaluation of the change in efficacy of erenumab when used long‐term for migraine prevention after initial established benefit in a veteran population	17
Issue Information	17

	17
Issue Information	17
Impact of model‐informed precision dosing on achievement of vancomycin exposure targets in pediatric patients with cystic fibrosis	16
Optimizing rapid diagnostics and diagnostic stewardship in Gram‐negative bacteremia	15
	15
Impact of SGLT2 inhibitors on cardiovascular outcomes in patients with heart failure with reduced ejection fraction	15
Apixaban and rivaroxaban use for atrial fibrillation in patients with obesity and BMI ≥50 kg/m2	15
Issue Information	14
Transplacental methadone exposure and risk of Neonatal Opioid Withdrawal Syndrome	14
Perioperative cangrelor in patients with recent percutaneous coronary intervention undergoing liver transplantation: A case series	14
Issue Information	14
Andexanet alfa versus PCC products for factor Xa inhibitor bleeding: A systematic review with meta‐analysis	14
Impact of medication intensification on 30‐day hospital readmissions in a geriatric trauma population: A multicenter cohort study	14
	14
Association of bleeding with serotonergic antidepressants in patients receiving left ventricular assist device support	13
A systematic review of direct acting antiviral therapies in hepatitis C virus‐negative liver transplant recipients of hepatitis C‐viremic donors	13
The incidence of torsades de pointes with peri‐operative low‐dose ondansetron administration	13
Comment on “The power and pitfalls of underpowered studies”	13
Hydroxyurea treatment for sickle cell anemia during pregnancy and lactation: Current evidence and knowledge gaps	13
Changes in serum potassium in people with type 2 diabetes taking sodium‐glucose co‐transporter‐2 inhibitors	12
Personalizing prevention: Advances in pharmacotherapy for HIV prevention	12
Pediatric considerations for pharmacogenetic selective serotonin reuptake inhibitors clinical decision support	12
Expanded use of sodium‐glucose cotransporter 2 inhibitors: Evidence beyond heart failure with reduced ejection fraction	12
Restrictive resuscitation in patients with sepsis and mortality: A systematic review and meta‐analysis with trial sequential analysis	12
External evaluation of neonatal vancomycin population pharmacokinetic models: Moving from first‐order equations to Bayesian‐guided therapeutic monitoring	12
A pilot study of ADRA2A genotype association with doses of dexmedetomidine for sedation in pediatric patients	12
Warfarin dosage in a postpartum woman while breastfeeding: A case report	12
Administration of rabies immunoglobulin: Improving evidence‐based guidance for wound infiltration	12
Pilot and feasibility study of dietary composition with elexacaftor‐tezacaftor‐ivacaftor concentrations in people with cystic fibrosis	12
Renal function estimating equations performance during pregnancy and postpartum	11
Assessment and management of iatrogenic withdrawal syndrome and delirium in pediatric intensive care units across Europe: An ESPNIC survey	11
	11
Meta‐analysis of clinical outcomes of PCSK9 modulators in patients with established ASCVD	11
Safety and efficacy of cefiderocol for off‐label treatment indications: A systematic review	11
Low‐dose adjuvant dexmedetomidine did not decrease propofol sedation requirements in children undergoing gastrointestinal endoscopy	10
Trends in the appropriateness of oral antibiotic prescriptions dispensed in the United States from 2010 to 2018	10
Effectiveness of sacubitril/valsartan versus aldosterone antagonists in heart failure with reduced ejection fraction: A retrospective cohort study	10
The association between urate‐lowering therapies and treatment‐related adverse events, liver damage, and major adverse cardiovascular events (MACE): A network meta‐analysis of randomized trials	10
The gray area of scientific adequacy	10
The role of tazobactam‐based combinations for the management of infections due to extended‐spectrum β‐lactamase‐producing Enterobacterales: Insights from the Society of Infectious Diseases Pharmacists	10
Corrigendum	10
Removing race and body surface area indexation for estimated kidney function based drug dosing: Aminoglycosides as justification of these principles	10
Real‐world effectiveness of monoclonal antibody inhibitors of PCSK9 in patients with heterozygous familial hypercholesterolemia: A retrospective cohort study	10
Association between household opioid prescriptions and risk for overdose among family members not prescribed opioids	10
Evolving resistance landscape in gram‐negative pathogens: An update on β‐lactam and β‐lactam‐inhibitor treatment combinations for carbapenem‐resistant organisms	10
Associating regulatory actions on diclofenac use with Danish trends in utilization by route of administration 1999–2023	9
Precision fluid and vasoactive drug therapy for critically ill patients	9
Contribution of pharmaceutical drugs of dependence to the incidence of neonatal abstinence syndrome in Western Australia between 2003 and 2018	9
Update and narrative review of avian influenza (H5N1) infection in adult patients	9
Consensus recommendations for use of maintenance immunosuppression in solid organ transplantation: Endorsed by the American College of Clinical Pharmacy, American Society of Transplantation, and the I	8

Buprenorphine initiation strategies for opioid use disorder and pain management: A systematic review	8
Exploring the frontier of cardiovascular pharmacotherapy	8
Issue Information	8
Acid‐suppressive drugs: A systematic review and network meta‐analysis of their nocturnal acid‐inhibitory effect	8
Glucagon: Its evolving role in the management of hypoglycemia	8
Impact of CYP3A5 phenotype on tacrolimus time in therapeutic range and clinical outcomes in pediatric renal and heart transplant recipients	8
Current pharmacotherapy management of children and adults with pericarditis: Prospectus for improved outcomes	8
Issue Information	8
Treatment of patients with serious infections due to carbapenem‐resistant Acinetobacter baumannii: How viable are the current options?	8
Systematic review and meta‐analysis of the correlation between bispectral index (BIS) and clinical sedation scales: Toward defining the role of BIS in critically ill patients	8
Precision‐based approaches to delirium in critical illness: A narrative review	8
A prospective study of filgrastim pharmacokinetics in morbidly obese patients compared with non‐obese controls	8
	7
Impact of proton pump inhibitors on sustained virologic response in veterans treated with sofosbuvir/velpatasvir for chronic hepatitis C virus: A retrospective cohort study	7
Metformin use is associated with reduced acute kidney injury following coronary artery bypass grafting in patients with type 2 diabetes: An inverse probability of treatment weighting analysis	7
Disease‐modifying therapies for amyloid transthyretin cardiomyopathy: Current and emerging medications	7
Issue Information	7
Path of least recurrence: A systematic review and meta‐analysis of fidaxomicin versus vancomycin for Clostridioides difficile infection	7
The potential role of GLP‐1 receptor agonists in osteoarthritis	7
Systematic literature review of insulin dose adjustments when initiating hemodialysis or peritoneal dialysis	7
Novel and replicated clinical and genetic risk factors for toxicity from high‐dose methotrexate in pediatric acute lymphoblastic leukemia	7
Impact of concurrent gabapentin or pregabalin with high‐dose melphalan in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplant	6
Response to comment on “Intravenous ketamine successfully treats treatment‐resistant catatonia in schizophrenia: A case report”	6
Effect of proton pump inhibitors versus histamine‐2 receptor antagonists on acute kidney injury in septic patients at high risk for developing stress ulcers	6
Fracture risk and opioid use in patients aged 17–64 years: An analysis of administrative claims data	6
Patient safety outcomes for continuous infusion vancomycin as outpatient parenteral antimicrobial therapy	6
Reflections on the future of biomedical publishing	6
A systematic review of opioid use and multimodal strategies in solid organ transplant recipients and living donors	6
	6
Therapeutic review of cabotegravir/rilpivirine long‐acting antiretroviral injectable and implementation considerations at an HIV specialty clinic	6
Aztreonam–avibactam: The dynamic duo against multidrug‐resistant gram‐negative pathogens	6
Pharmacogenetics ofP2Y12receptor inhibitors	6
Issue Information	5
Effects of aging on clinical outcomes in patients receiving genotype‐guided P2Y12 inhibitor selection after percutaneous coronary intervention	5
Issue Information	5
Physiologically based pharmacokinetic models for predicting lamotrigine exposure and dose optimization in pediatric patients receiving combination therapy with carbamazepine or valproic acid	5
GLP‐1RA‐induced delays in gastrointestinal motility: Predicted effects on coadministered drug absorption by PBPK analysis	5
Reduced risk of NSAID‐Induced adverse events with concomitant use of misoprostol (MICRO study)	5
Emerging therapies for eosinophilic esophagitis	5
Response to comment on “Dosing implications for liposomal amphotericin B in pregnancy”	5
Elbasvir/grazoprevir administered for 12 weeks via percutaneous endoscopic gastrostomy tube achieves sustained virologic response: A case report and a review of the literature	5
Randomized controlled trial to compare safety and efficacy of mycophenolate vs. cyclosporine after rituximab in children with steroid‐resistant nephrotic syndrome	5
Efficacy and safety of mirikizumab compared with currently approved biologic drugs for the treatment of ulcerative colitis: A systematic review and network meta‐analysis	5
Role of maternal COVID‐19 vaccination in providing immunological protection to the newborn	5
Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment‐experienced and/or have multidrug‐resistant HIV‐1: Endorse	5
Issue Information	5
Drug repurposing of dextromethorphan as a cellular target for the management of influenza	5
Impact of pre‐lung transplant statin use on the development of primary graft dysfunction	5
TT genotype of the MMP‐9‐1562C/T polymorphism may be a risk factor for thrombolytic therapy‐induced hemorrhagic complications after acute ischemic stroke	5
Safety of elexacaftor/tezacaftor/ivacaftor dose reduction: Mechanistic exploration through physiologically based pharmacokinetic modeling and a clinical case series	5
Use of therapeutic drug monitoring to characterize cefepime‐related neurotoxicity	5
Evaluation of anti‐factor Xa concentrations using a body mass index‐based enoxaparin dosing protocol for venous thromboembolism prophylaxis in trauma patients	5
Low‐dose versus standard‐dose four‐factor prothrombin complex concentrate for factor‐Xa inhibitor reversal in spontaneous and traumatic intracranial hemorrhage	4
Oral stepdown in Gram‐positive bloodstream infections: A step in the right direction	4
Management of invasive candidiasis: A focus on rezafungin, ibrexafungerp, and fosmanogepix	4
Comment on “Evaluation of the safety and tolerability of intravenous undiluted levetiracetam at a pediatric institution”	4
Characterization of antiplatelet response to low‐dose cangrelor utilizing platelet function testing in neuroendovascular patients	4
High prescribing of antibiotics is associated with high prescribing of opioids in medical and dental providers	4
Biomarkers in the intensive care setting: A focus on using procalcitonin and C‐reactive protein to optimize antimicrobial duration of therapy	4
NR3C2 genotype is associated with response to spironolactone in diastolic heart failure patients from the Aldo‐DHF trial	4
Hydroxyurea for children with sickle cell disease in sub‐Saharan Africa: A summary of the evidence, opportunities, and challenges	4
Fluoroquinolone‐associated adverse events of interest among hospitalized veterans affairs patients with community‐acquired pneumonia who were treated with a fluoroquinolone: A focus on tendonitis,	4
A Retrospective Analysis Comparing Post‐Operative Bleeding with Various Doses of Aspirin after Lower Extremity Joint Arthroplasty or Revision	4
Temporal shifts in safety and efficacy profile of mycophenolate mofetil 2 g versus 3 g daily early after heart transplantation	4
Corticosteroid use in ARDS and its application to evolving therapeutics for coronavirus disease 2019 (COVID‐19): A systematic review	4
Serum potassium response to single‐dose sodium zirconium cyclosilicate for the treatment of asymptomatic hyperkalemia in hospitalized patients	4
Venlafaxine deprescribing and thyroid function	4
The efficacy and safety of sodium‐glucose cotransporter‐2 inhibitors in solid organ transplant recipients: A scoping review	4
Optimal starting dosing regimen of intravenous oxytocin for labor induction based on the population kinetic‐pharmacodynamic model of uterine contraction frequency	4
Issue Information	3
	3
Is ketamine infusion effective and safe as an adjuvant of sedation in the PICU? Results from the Ketamine Infusion Sedation Study (KISS)	3
Comparison of different sustained‐release opioids and acute respiratory conditions in patients with cancer and chronic kidney disease	3
Determination of vancomycin exposure target and individualized dosing recommendations for critically ill patients undergoing continuous renal replacement therapy	3
	3
A systematic review of the drug–drug interaction between statins and colchicine: Patient characteristics, etiologies, and clinical management strategies	3
Pre‐transplant amiodarone use does not affect long‐term heart transplant survival	3
Reversal of apixaban and rivaroxaban with andexanet alfa prior to invasive or surgical procedures	3
Issue Information	3
Pharmacokinetic parameters over time during sepsis and the association of target attainment and outcomes in critically ill children and young adults receiving ceftriaxone	3

Albuminuria‐based stratification of end‐stage kidney disease progression and mortality with sodium‐glucose cotransporter 2 inhibitors (SGLT2i): A retrospective cohort study in type 2 diabet	3
New ways of using old antibiotics in pediatrics: Focus on fosfomycin	3
Issue Information	3
Authors response to critique of “angiotensin‐converting enzyme inhibitors reduce community‐acquired pneumonia hospitalization and mortality”	3
	3
“Comment on ‘international consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimi	3
Issue Information	3
Scoping review of augmented renal clearance in critically ill pediatric patients	3
Issue Information	3
Gut microbiome health and dysbiosis: A clinical primer	3
Assessment of a modified MINDS‐based protocol for management of alcohol withdrawal syndrome on an inpatient medical service	3
Cross‐titration from risperidone to clozapine utilizing clozapine serum concentrations: A case report	3
Chemotherapy‐associated cardiomyopathy: Mechanisms of toxicity and cardioprotective strategies	3
Correction to “Comparative adherence trajectories of oral disease‐modifying agents in multiple sclerosis”	3
Evaluation of the safety and tolerability of intravenous undiluted levetiracetam at a pediatric institution	3
Sulbactam‐durlobactam: A novel β‐lactam‐β‐lactamase inhibitor combination targeting carbapenem‐resistant Acinetobacter baumannii infections	3
	3
Bicarbonate as a predictor of successful insulin transition in critically ill patients with diabetic ketoacidosis: A retrospective cohort study	3
Comment on “Tacrolimus in the treatment of childhood nephrotic syndrome: Machine learning detects novel biomarkers and predicts efficacy”	3
	3
Issue Information	3
A review of antibiotic safety in pregnancy—2025 update	3
Management of noncardiovascular comorbidities in patients with heart failure with reduced ejection fraction	3
Oral fluoroquinolones and risk of aortic aneurysm or dissection: A nationwide population‐based propensity score‐matched cohort study	3
Response to comment on “International consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society	3
Prescribing cascades in ambulatory care: A structured synthesis of evidence	3
Patient risk factors for opioid‐related adverse drug events in hospitalized patients: A systematic review	3
Statin‐associated muscle symptoms—A review: Individualizing the approach to optimize care	3
Dexmedetomidine for prevention of opioid/benzodiazepine withdrawal syndrome in pediatric intensive care unit: Interim analysis of a randomized controlled trial	3
A retrospective analysis of bleeding risk with rivaroxaban, enoxaparin, and aspirin following total joint arthroplasty or revision	3
Consensus recommendations for use of long‐acting antiretroviral medications in the treatment and prevention of HIV‐1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pha	2
International consensus recommendations for the use of prolonged‐infusion beta‐lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy	2
Steno‐sphere: Navigating the enigmatic world of emerging multidrug‐resistantStenotrophomonas maltophilia	2
From bottle to bedside: Implementation considerations and antimicrobial stewardship considerations for bloodstream infection rapid diagnostic testing	2
Is reversal of anticoagulants necessary in neurologically intact traumatic intracranial hemorrhage?	2
Pharmacogenomics and beyond! Customized pharmacotherapy for solid organ transplant recipients	2
Developing precision‐based multidisciplinary pharmacotherapy management plans in the critically ill	2
Risk of fall‐related injury and all‐cause hospitalization of select concomitant central nervous system medication prescribing in older adult persistent opioid users: A case‐time‐control analysis	2
Vancomycin: An analysis and evaluation of eight population pharmacokinetic models for clinical application in general adult population	2
Issue Information	2
Use of naldemedine is associated with reduced incidence of hyperactive delirium in cancer patients with opioid‐induced constipation: A nationwide retrospective cohort study in Japan	2
The effect of antipsychotic treatment on hormonal, inflammatory, and metabolic biomarkers in healthy volunteers: A systematic review and meta‐analysis	2
Issue Information	2
Cannabinoids for obstructive sleep apnea: A systematic review	2
Multicenter study evaluating target attainment of anti‐Factor Xa levels using various enoxaparin prophylactic dosing practices in adult trauma patients	2
Combination eravacycline therapy for ventilator‐associated pneumonia due to carbapenem‐resistant Acinetobacter baumannii in patients with COVID‐19: A case series	2
Prophylaxis for Pneumocystis jirovecii pneumonia in patients with inflammatory bowel disease: A systematic review	2
The immunomodulatory effects of opioids and implications for intensive care unit populations	2
Morphomics‐informed population pharmacokinetic and physiologically‐based pharmacokinetic modeling to optimize cefazolin surgical prophylaxis	2
Lactated Ringer's versus normal saline in the management of acute diabetic ketoacidosis (RINSE‐DKA)	2
Population pharmacokinetics of linezolid and its major metabolites PNU‐142300 and PNU‐142586 in adult patients	2
Outcomes of adult patients in the intensive care unit with Pseudomonasaeruginosa pneumonia who received an active anti‐pseudomonal β‐lactam: Does “S” equal success in the presence of res	2
TheMPRINTHub Data, Model, Knowledge and Research Coordination Center: Bridging the gap in maternal–pediatric therapeutics research through data integration and pharmacometrics	2
Evaluation of methotrexate Pharmacogenomic variation to predict acute neurotoxicity in children with acute lymphoblastic leukemia	2
Issue Information	2
A propensity score‐matching analysis of angiotensin‐converting enzyme inhibitor and angiotensin receptor blocker exposure on in‐hospital mortality in patients with acute respiratory failure	2
Incidence of serious infections in the working‐age Japanese adult population with rheumatoid arthritis treated with tumor necrosis factor‐α inhibitors and interleukin‐6 inhibitors: A nationwide retros	2
	2
Management of diffuse alveolar hemorrhage in the hematopoietic stem cell transplantation population: A systematic review	2
Antimicrobial pharmacokinetics and dosing in critically ill adults receiving prolonged intermittent renal replacement therapy: A systematic review	2
Genetic polymorphisms and major bleeding risk during vitamin K antagonists treatment: The BLEEDS case‐cohort	2
Early combination therapy with immunoglobulin and steroids is associated with shorter ICU length of stay in Multisystem Inflammatory Syndrome in Children (MIS‐C) associated with	2
	2
	2
Issue Information	2
Pneumococcal vaccination—A literature review and practice guideline update	1
Clinical outcomes associated with anti‐Xa‐monitored enoxaparin for venous thromboembolism prophylaxis	1
Transfer of antibiotics and their metabolites in human milk: Implications for infant health and microbiota	1
Leveraging physiologically based pharmacokinetic modeling to optimize dosing for lopinavir/ritonavir with rifampin in pediatric patients	1
Adverse Effects of Antidepressant Medications and their Management in Children and Adolescents	1
Issue Information	1
Insulin NPH for steroid‐induced hyperglycemia: Predictors for success	1
The incidence of cytomegalovirus and BK polyomavirus infections in kidney transplant patients receiving mTOR inhibitors: A systematic review and meta‐analysis	1
Analysis of fentanyl pharmacokinetics, and its sedative effects and tolerance in critically ill children	1
Maternal and neonatal outcomes associated with treating hypertension in pregnancy at different thresholds	1
Evaluating the evidence for sacubitril/valsartan across the continuum of heart failure	1
	1
	1
Cefazolin in the treatment of central nervous system infections: A narrative review and recommendation	1
Adequacy of cefepime concentrations in the early phase of critical illness: A case for precision pharmacotherapy	1
	1
Clinical Impact of GLP‐1 receptor agonists in veterans receiving basal‐bolus insulin	1
Response to comment on “Evaluation of the safety and tolerability of intravenous undiluted levetiracetam at a pediatric institution”	1
Use of bivalirudin after initial heparin management among adult patients on long‐term venovenous extracorporeal support as a bridge to lung transplant: A case series	1
	1
Issue Information	1
Effect of cilostazol on preventing paclitaxel‐induced neuropathy in patients with breast cancer: A randomized controlled trial	1
Use of oral tetracyclines in the treatment of adult outpatients with skin and skin structure infections: Focus on doxycycline, minocycline, and omadacycline	1
Comparative effectiveness of sodium‐glucose cotransporter‐2 inhibitors among patients with heart failure with preserved ejection fraction	1
Unsupervised machine learning analysis to identify patterns of ICU medication use for fluid overload prediction	1
Effects of GLP‐1 receptor agonists on cardiovascular outcomes in patients with type 2 diabetes and chronic kidney disease: A systematic review and meta‐analysis	1
Prospective, randomized, controlled, trial to assessASADOSingby body mass index inHEalthyvolunteers (DOSEstudy)	1
	1
Personalized antiseizure medication therapy in critically ill adult patients	1
Exploring variations in recommended first‐choice therapy for complicated urinary tract infections in males: Insights from outpatient settings across age, race, and ethnicity	1